Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
83.81
-2.93 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
84.30
+0.49 (0.58%)
Pre-market: Apr 29, 2026, 7:22 AM EDT
Nektar Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -164.08 | -118.96 | -276.06 | -368.2 | -523.84 | |
| Depreciation & Amortization | 1.03 | 4.39 | 7.82 | 13.03 | 14.15 | |
| Loss (Gain) From Sale of Assets | - | -40.39 | 1.3 | -3.33 | - | |
| Asset Writedown & Restructuring Costs | 4.44 | 8.33 | 111.83 | 70.71 | 16.7 | |
| Loss (Gain) on Equity Investments | 8.73 | - | - | - | - | |
| Stock-Based Compensation | 12.65 | 21.61 | 33.39 | 57.32 | 94.67 | |
| Other Operating Activities | -34.26 | -44.45 | -50.94 | -74.04 | 8.63 | |
| Change in Accounts Receivable | - | -3.05 | 4.78 | 16.51 | 12.4 | |
| Change in Inventory | - | 0.5 | 0.7 | -3.4 | -0.51 | |
| Change in Accounts Payable | -0.63 | 2.67 | -2.88 | 3.1 | -11.69 | |
| Change in Other Net Operating Assets | -36.39 | -6.36 | -22.53 | -15.72 | -23.17 | |
| Operating Cash Flow | -208.51 | -175.71 | -192.61 | -304.01 | -412.66 | |
| Capital Expenditures | -0.87 | -1.47 | -0.87 | -5.68 | -14.99 | |
| Sale of Property, Plant & Equipment | - | - | 1.25 | 13.2 | - | |
| Investment in Securities | -0.33 | 78.65 | 139.18 | 358.32 | 217.77 | |
| Other Investing Activities | - | 65.39 | - | - | - | |
| Investing Cash Flow | -1.2 | 142.57 | 139.56 | 365.84 | 202.78 | |
| Long-Term Debt Issued | 180.85 | - | - | - | - | |
| Net Debt Issued (Repaid) | 180.85 | - | - | - | - | |
| Issuance of Common Stock | 0.87 | 0.12 | 0.03 | 0.76 | 33.24 | |
| Repurchase of Common Stock | - | -3 | - | - | - | |
| Other Financing Activities | -1.15 | 45 | - | 0.75 | 3 | |
| Financing Cash Flow | 180.57 | 42.12 | 0.03 | 1.51 | 36.24 | |
| Foreign Exchange Rate Adjustments | 0.01 | -0 | 0.06 | -0.33 | -0.09 | |
| Net Cash Flow | -29.14 | 8.98 | -52.95 | 63.01 | -173.74 | |
| Free Cash Flow | -209.38 | -177.18 | -193.47 | -309.68 | -427.65 | |
| Free Cash Flow Margin | -379.09% | -180.01% | -214.68% | -336.41% | -419.65% | |
| Free Cash Flow Per Share | -12.41 | -12.92 | -15.27 | -24.82 | -35.00 | |
| Cash Income Tax Paid | -0.2 | 0.08 | 2.66 | 0.27 | 0.33 | |
| Levered Free Cash Flow | -108.23 | -43.69 | -63.63 | -101.13 | -234.18 | |
| Unlevered Free Cash Flow | -91.86 | -26.12 | -47.8 | -83.06 | -204.61 | |
| Change in Working Capital | -37.02 | -6.24 | -19.94 | 0.49 | -22.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.